approval · primary record
CABOZANTINIB S-MALATE
FDA · NDA · 2025-10-09
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-10-09 |
| Brand | CABOMETYX |
| Sponsor | EXELIXIS INC |
| Route | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:30:38.919Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:CABOZANTINIB S-MALATE:2025-10-09
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.